Safety specialist Halma capped its remarkable run by entering the FTSE 100 – but more will come.
Articles written by Dr Mike Tubbs
ASML’s cutting-edge technology will capitalise on the growing demand for computer chips, says Mike Tubbs.
Investing in a booming industry can be a risky business – only a lucky few will strike gold and produce the hot products of the future. There’s a much safer way to bet on fast-growing sectors, says Dr Mike Tubbs.
Reading your genome is becoming easier and cheaper. That makes it possible to figure out which medicines will work for you. Dr Mike Tubbs picks the companies best-placed to profit.
Technological advances have transformed our day-to-day lives – and made fortunes for sharp-eyed investors. But how do you spot future innovators? Dr Mike Tubbs investigates.
Companies that spend a lot on research are promising candidates for super-charged growth. But how can you tell which ones are wasting their money? Dr Mike Tubbs explains.
There is currently no cure for MS, Alzheimer’s and Parkinson’s diseases but research gallops on. There will be big rewards for the first drug company to break through, says Dr Mike Tubbs.
A new generation of anti-cancer drugs looks promising. There are four main ways to invest, with varying levels of risk. Dr Michael Tubbs explains.